Functional adaptation and remodeling of pulmonary artery in flow-induced pulmonary hypertension

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 6 58-6, 2005, Pages

  Lam, Chen Fuh ^a,b   Peterson, Timothy E ^a   Croatt, Anthony J ^a   Nath, Karl A ^a   Katusic, Zvonimir S ^a,b,c  

^a Mayo Clinic   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Cyclooxygenase 2; Endothelial nitric oxide synthase; Endothelium; Guanosine 3 ,5 cyclic monophosphate

Indexed keywords

ACETYLCHOLINE; CYCLIC GMP; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDOMETACIN; NITRIC OXIDE; NITRIC OXIDE DONOR; PROSTANOID; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTOCAVAL FISTULA; ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; HEART LEFT RIGHT SHUNT; HISTOPATHOLOGY; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; HYPERTENSION, PULMONARY; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTION;

EID: 28144442736     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00375.2005     Document Type: Article

References (53)

1. 2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease. Circulation 88: 2117-2122, 1993.
2. Bando K, Turrentine MW, Sharp TG, Sekine Y, Sun K, Sekine E, and Brown JW. Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management. J Thorac Cardiovasc Surg 112: 1600-1607, 1996.
3. Bauer J, Thul J, Valeske K, Muller M, Michel-Behnke I, Gehron J, Schranz D, and Akinturk H. Perioperative management in pediatric heart transplantation. Thorac Cardiovasc Surg 53: S155-S158, 2005.
4. Berger RM, Geiger R, Hess J, Bogers JJC, and Mooi WJ. Altered arterial expression patterns of inducible and endothelial nitric oxide synthase in pulmonary plexogenic arteriopathy caused by congenital heart disease. Am J Respir Crit Care Med 163: 1493-1499, 2001.
5. Black SM, Bekker JM, McMullan DM, Parry AJ, Ovadia B, Reinhartz O, Lakshminrushimha S, Mata-Greenwood E, Steinhorn RH, and Fineman JR. Alterations in nitric oxide production in 8-wk-old lambs with increased pulmonary blood flow. Pediatr Res 52: 233-244, 2002.
6. Black SM, Fineman JR, Steinhorn RH, Bristow J, and Soifer SJ. Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Heart Circ Physiol 275: H1643-H1651, 1998.
7. Black SM, Sanchez LS, Mata-Greenwood E, Bekker JM, Steinhorn RH, and Fineman JR. sGC and PDE5 are elevated in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 281: L1051-L1057, 2001.
8. Boo YC and Jo H. Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinase. Am J Phyiol Cell Physiol 285: C499-C508, 2003.
9. Brennan LA, Steinhorn RH, Wedgwood S, Mata-Greenwood E, Roark EA, Russell JA, and Black SM. Increased Superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase. Circ Res 92: 683-691, 2003.
10. Celermajer DS, Cullen S, and Deanfield JE. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation 87: 440-446, 1993.
11. Chou TF, Wu MS, Chien CT, Yu CC, and Chen CF. Enhanced expression of nitric oxide synthase in the early stage after increased pulmonary blood flow in rats. Eur J Cardiothorac Surg 21: 331-336, 2002.
12. Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, and Loyd JE. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 327: 70-75, 1992.
13. Corson MA, James NL, Latta SE, Nerem RM, Berk BC, and Harrison DG. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ Res 79: 984-991, 1996.
14. D'Uscio LV, Baker TA, Mantilla CB, Smith L, Weiler D, Sieck GC, and Katusic ZS. Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 21: 1017-1022, 2001.
15. D'Uscio LV, Milstien S, Richardson D, Smith L, and Katusic AS. Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity. Circ Res 92: 88-95, 2003.
16. Dai ZK, Tan MS, Chai CY, Chen IJ, Jeng AY, and Wu JR. Effects of increased pulmonary flow on the expression of endothelial nitric oxide synthase and endothelin-1 in the rat. Clin Sci (Lond) 103: 289S-293S, 2002.
17. Dinh-Xuan AT, Higenbottam TW, Clelland C, Pepke-Zaba J, Cremona G, and Wallwork J. Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome. Br J Pharmacol 99: 9-10, 1990.
18. Epting CL, Wolfe RR, Abman SH, Deutsch GH, and Ivy D. Reversal of pulmonary hypertension associated with plexiform lesions in congenital heart disease: a case report. Pediatr Cardiol 23: 182-185, 2002.
19. Erami C, Zhang H, Tanoue A, Tsujimoto G, Thomas SA, and Faber JE. Adrenergic catecholamine trophic activity contributes to flow-mediated arterial remodeling. Am J Physiol Heart Circ Physiol 289: H744-H753, 2005.
20. Fike CD, Kaplowitz MR, and Pfister SL. Arachidonic acid metabolites and an early stage of pulmonary hypertension in chronically hypoxic newborn pigs. Am J Physiol Lung Cell Mol Physiol 284: L316-L323, 2003.
21. Fishman AP. Changing concepts of the pulmonary plexiform lesion. Physiol Res 49: 485-492, 2000.
22. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, and Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399: 597-601, 1999.
23. 2 concentration in pulmonary hypertension associated with congenital heart disease. Circulation 90: 2952-2955, 1994.
24. Hanley FL, Heinermann MK, Jonas RA, Mayer JE, Cook NR, Wessel DL, and Castaneda AR. Repair of truncus arteriosus in the neonate. J Thorac Cardiovasc Surg 105: 1047-1056, 1993.
25. Hatt PY, Rakusan K, Gastineau P, and Laplace M. Morphometry and ultrastructure of heart hypertrophy induced by chronic volume overload (aorto-caval fistula in the rat). J Mol Cell Cardiol 11: 989-998, 1979.
26. Hoffman JI, Rudolph AM, and Heymann MA. Pulmonary vascular disease with congenital heart lesions: pathologic features and causes. Circulation 64: 873-877, 1981.
27. Jones GT, Stehbens WE, and Martin BJ. Ultrastructural changes in arteries proximal to short-term experimental carotid-jugular arteriovenous fistulae in rabbits. Int J Exp Pathol 75: 225-232, 1994.
28. Kim-Park S and Ku DD. Garlic elicits nitric oxide-dependent relaxation and inhibits hypoxic pulmonary vasoconstriction in rats. Clin Exp Pharmacol Physiol 27: 780-786, 2000.
29. Kurotobi S, Sano T, Kogaki S, Matsushita T, Miwatani T, Takeuchi M, Matsuda H, and Okada S. Bidirectional cavopulmonary shunt with right venticular outflow patency: the impact of pulsatility on pulmonary endothelial function. J Thorac Cardiovasc Surg 121: 1161-1168, 2001.
30. Lam CF, Croatt AJ, Richardson D, Nath KA, and Katusic ZS. Heart failure increases protein expression and enzymatic activity of heme oxygenase-1 in the lung. Cardiovasc Res 65: 203-210, 2005.
31. Masuda H, Saito N, Kawamura K, Shozawa T, Kanazawa A, and Sageshima M. Flow loaded canine carotid artery. II. Ultrastructural changes in the subendothelial layer. Acta Pathol Jpn 37: 239-251, 1987.
32. Masuda H, Zhuang YJ, Singh TM, Kawamura K, Murakami M, Zarins CK, and Glagov S. Adaptive remodeling of internal elastic lamina and endothelial lining during flow-induced arterial enlargement. Arterioscler Thromb Vasc Biol 19: 2298-2307, 1999.
33. Mata-Greenwood E, Meyrick B, Soifer SJ, Fineman JR, and Black SM. Expression of VEGF and its receptors Flt-1 and Flk-1/KDR is altered in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 285: L222-L231, 2003.
34. Mathew R and Gewitz MH. Pulmonary hypertension in infancy and childhood. Heart Dis 2: 362-368, 2000.
35. Mikhail G, Chester AH, Gibbs JSR, Borland JAA, Banner NR, and Yacoub MH. Role of vasoactive mediators in primary and secondary pulmonary hypertension. Am J Cardiol 82: 254-255, 1998.
36. Millatt LJ, Whitley GS, Li D, Leiper JM, Siragy HM, Carey RM, and Johns RA. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension. Circulation 108: 1493-1498, 2003.
37. Nakhoul F, Yigla M, Gilman R, Reisner SA, and Abassi Z. The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access. Nephrol Dial Transplant 20: 1686-1692, 2005.
38. Nath KA, Kanakiriya SK, Grande JP, Croatt AJ, and Katusic ZS. Increased venous proinflammatory gene expression and intimal hyperplasia in an aortocaval fistula model in the rat. Am J Pathol 162: 2079-2090, 2003.
39. Nava E, Farre AL, Moreno C, Casado S, Moreau P, Cosentino F, and Luscher TF. Alterations to the nitric oxide pathway in the spontaneously hypertensive rat. J Hypertens 16: 609-615, 1998.
40. Nishimura T, Faul JL, Berry GJ, Kao PN, and Pearl RG. Effect of a surgical aortocaval fistula on monocrotaline-induced pulmonary hypertension. Crit Care Med 31: 1213-1218, 2003.
41. Papapetropoulos A, Gardia-Cardena G, Madri JA, and Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100: 3131-3139, 1997.
42. Pearce JD, Li J, Edwards MS, English WP, and Geary RL. Differential effects of Rho-kinase inhibition on artery wall mass and remodeling. J Vasc Surg 39: 223-228, 2004.
43. Qi J, Du J, Tang X, Li J, Wei B, and Tang C. The upregulation of endothelial nitric oxide synthase and urotensin-II is associated with pulmonary hypertension and vascular diseases in rats produced by aortocaval shunting. Heart Vessels 19: 81-88, 2004.
44. Schulze-Neick I, Li J, Penny DJ, and Redington AN. Pulmonary vascular resistance after cardiopulmonary bypass in infants: effect on postoperative recovery. J Thorac Cardiovasc Surg 121: 1033-1039, 2001.
45. Schulze-Neick I, Li J, Reader JA, Shekerdemian L, Redington AN, and Penny DJ. The endothelin antagonist BQ123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease. J Thorac Cardiovasc Surg 124: 435-441, 2002.
46. Shirasaki Y, Kolm P, Nickols GA, and Lee TJ. Endothelial regulation of cyclic GMP and vascular responses in hypertension. J Pharmacol Exp Ther 245: 53-58, 1988.
47. Steinhorn RH, Russell JA, Lakshminrusimha S, Gugino SF, Black SM, and Fineman JR. Altered endothelium-dependent relaxations in lambs with high pulmonary blood flow and pulmonary hypertension. Am J Physiol Heart Circ Physiol 280: H311-H317, 2001.
48. Suzuki Y, Yamamoto T, Mabuchi Y, Tada T, Suzumori K, Soji T, Herbert DC, and Itoh T. Ultrastructural changes in omental resistance artery in women with preeclampsia. Am J Obstet Gynecol 189: 216-221, 2003.
49. Tanimoto T, Jin ZG, and Berk BC. Transactivation of vascular endothelial growth factor (VEGF) receptor Flk/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric oxide. J Biol Chem 277: 42997-43001, 2002.
50. Tuder RM, Cool CD, Geraci MW, Wang J, Abman SH, Wright L, Badesch D, and Voelkel NF. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med 159: 1925-1932, 1999.
51. Vaziri ND, Ni Z, and Oveisi F. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 31: 1248-1254, 1998.
52. Wei B, Du J, Qi J, Li J, and Tang C. L-arginine impacts pulmonary vascular structure in rats with an aortocaval shunt. J Surg Res 108: 20-31, 2002.
53. Yigla M, Nakhoul F, Sabag A, Tov N, Gorevich B, Abassi Z, and Reisner SA. Pulmonary hypertension in patients with end-stage renal disease. Chest 123: 1577-1582, 2003.